Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,674 | 84 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $487.11 | 15 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $313.51 | 13 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $198.52 | 17 | $0 (2022) |
| Cranial Technologies, Inc | $121.53 | 8 | $0 (2022) |
| Phadia US Inc. | $97.28 | 6 | $0 (2024) |
| Shire North American Group Inc | $96.31 | 6 | $0 (2019) |
| Corium, LLC | $85.24 | 3 | $0 (2024) |
| Global Blood Therapeutics, Inc. | $84.32 | 4 | $0 (2021) |
| ARBOR PHARMACEUTICALS, INC. | $29.89 | 2 | $0 (2018) |
| Adlon Therapeutics L.P. | $27.31 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $596.21 | 20 | Supernus Pharmaceuticals, Inc. ($373.49) |
| 2023 | $116.87 | 5 | Supernus Pharmaceuticals, Inc. ($87.70) |
| 2022 | $152.45 | 9 | Cranial Technologies, Inc ($64.94) |
| 2021 | $235.56 | 18 | Takeda Pharmaceuticals U.S.A., Inc. ($125.89) |
| 2020 | $149.91 | 10 | Takeda Pharmaceuticals U.S.A., Inc. ($41.26) |
| 2019 | $177.61 | 7 | Ironshore Pharmaceuticals Inc. ($146.15) |
| 2018 | $109.73 | 7 | Phadia US Inc. ($35.61) |
| 2017 | $135.51 | 8 | Shire North American Group Inc ($49.75) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/21/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $17.41 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/15/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $21.57 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 09/20/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $19.69 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 08/28/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $117.57 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/28/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $3.30 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/26/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $21.89 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 08/22/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/16/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 05/16/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $23.83 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 05/09/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Gastroenterology | ||||||
| 04/10/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $23.84 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 04/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 03/12/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $13.75 | General |
| Category: Allergy/Immunology | ||||||
| 03/06/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $19.55 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 02/15/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $32.82 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 01/23/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $63.56 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $129.32 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/21/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $22.57 | General |
| Category: PSYCHOLOGY | ||||||
| 11/13/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/27/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $22.16 | General |
| Category: PSYCHOLOGY | ||||||
| 08/24/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $18.56 | General |
| Category: PSYCHOLOGY | ||||||
| 05/25/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $24.41 | General |
| Category: PSYCHOLOGY | ||||||
About Dr. Melaney Caldwell, MD
Dr. Melaney Caldwell, MD is a Pediatrics healthcare provider based in Prince George, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1235110453.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melaney Caldwell, MD has received a total of $1,674 in payments from pharmaceutical and medical device companies, with $596.21 received in 2024. These payments were reported across 84 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,674).
Practice Information
- Specialty Pediatrics
- Location Prince George, VA
- Active Since 11/07/2005
- Last Updated 07/18/2012
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1235110453
Products in Payments
- Qelbree (Drug) $373.49
- VYVANSE (Drug) $268.52
- JORNAY PM (Drug) $167.36
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $146.15
- Doc Band (Device) $121.53
- QELBREE (Drug) $113.62
- ImmunoCAP (Device) $97.28
- OXBRYTA (Drug) $84.32
- Azstarys (Drug) $61.99
- ADHANSIA XR (Drug) $27.31
- SYNAGIS (Drug) $24.18
- AZSTARYS (Drug) $23.25
- Adzenys XR-ODT (Drug) $20.85
- EUCRISA (Drug) $18.67
- TUDORZA PRESSAIR (Drug) $16.53
- Evekeo (Drug) $15.89
- Bylvay (Drug) $14.89
- MYDAYIS (Drug) $14.35
- Sklice (Drug) $14.00
- TZIELD (Biological) $13.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.